Kayne Anderson Rudnick Investment Management LLC Takes Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Kayne Anderson Rudnick Investment Management LLC bought a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 1,087,620 shares of the company's stock, valued at approximately $84,932,000. Kayne Anderson Rudnick Investment Management LLC owned about 2.20% of Prestige Consumer Healthcare at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of PBH. Avior Wealth Management LLC grew its holdings in Prestige Consumer Healthcare by 1,570.7% during the fourth quarter. Avior Wealth Management LLC now owns 8,554 shares of the company's stock worth $668,000 after acquiring an additional 8,042 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Prestige Consumer Healthcare by 5.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock valued at $49,667,000 after buying an additional 33,844 shares during the last quarter. Norges Bank acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $40,009,000. Barclays PLC boosted its holdings in Prestige Consumer Healthcare by 346.3% during the third quarter. Barclays PLC now owns 92,444 shares of the company's stock valued at $6,665,000 after purchasing an additional 71,730 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in Prestige Consumer Healthcare by 1,073.3% during the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock valued at $15,923,000 after purchasing an additional 186,524 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Oppenheimer lifted their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research note on Thursday, February 13th. DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Canaccord Genuity Group raised their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Finally, Royal Bank of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, Prestige Consumer Healthcare has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Insider Activity at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the sale, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.60% of the stock is owned by insiders.

Prestige Consumer Healthcare Stock Up 1.5%

PBH traded up $1.24 during trading on Friday, hitting $85.72. The company had a trading volume of 104,271 shares, compared to its average volume of 297,604. The company has a market cap of $4.24 billion, a PE ratio of 20.08, a P/E/G ratio of 2.69 and a beta of 0.44. The business has a 50-day moving average of $83.58 and a 200-day moving average of $82.39. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare Inc. has a 1-year low of $62.35 and a 1-year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The company had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. During the same period in the previous year, the company earned $1.02 earnings per share. The company's quarterly revenue was up 7.0% compared to the same quarter last year. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.